Our Pricing

Wegovy Order Online UK - Complete Dosing Guide

Published on: June 03, 2026

When you wegovy order online uk through Cured Pharmacy, you'll access all doses from 0.25mg to 2.4mg with genuine UK-licensed stock from £79.00. Our UK-registered prescribers complete your free clinical assessment in under 3 minutes, and we dispatch directly from our GPhC-registered pharmacy with 100% discreet packaging.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics the natural hormone GLP-1, which regulates appetite by acting on areas of the brain that control hunger and food intake.

In the STEP 1 clinical trial, participants using Wegovy 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. The medication works by slowing gastric emptying, increasing feelings of fullness after meals, and reducing overall caloric intake. These mechanisms combine to create a sustained weight loss effect when used alongside a reduced-calorie diet and increased physical activity [2].

All Wegovy Doses Available from UK Stock

Cured Pharmacy maintains complete UK stock of all five Wegovy dose strengths, ensuring you can progress through the full titration schedule without treatment interruption. The complete dose escalation follows NICE-endorsed guidelines to minimise gastrointestinal side effects whilst optimising weight loss outcomes [3].

Each Wegovy pen delivers four weekly doses at the specified strength. Your UK prescriber will determine your starting dose based on your clinical assessment, and you'll typically begin with the 0.25mg dose before gradually increasing every four weeks. This gradual titration allows your body to adjust to the medication and significantly reduces the likelihood of nausea and other common side effects.

Wegovy Titration Schedule

The standard Wegovy dose escalation begins at 0.25mg weekly for four weeks, then increases to 0.5mg for four weeks, followed by 1.0mg, 1.7mg, and finally the maintenance dose of 2.4mg weekly [3]. Each dose increase occurs at four-week intervals, subject to your prescriber's clinical judgement and your tolerance to the medication. Some patients may require a slower titration if they experience persistent gastrointestinal symptoms, whilst others progress smoothly through the full schedule. Your UK prescriber will review your progress at each stage and adjust the plan accordingly.

Wegovy Order Online Process at Cured Pharmacy

Ordering Wegovy through Cured Pharmacy begins with a free online consultation that takes under 3 minutes to complete. You'll answer questions about your medical history, current medications, weight loss goals, and any previous experience with GLP-1 treatments. Our UK-registered prescribers, working under superintendent pharmacist Tarun Kumar (GPhC 2233073), review every consultation individually to ensure Wegovy is clinically appropriate and safe for you.

Once approved, we dispense your Wegovy prescription from our GPhC-registered pharmacy (9012511) and dispatch with discreet packaging via tracked courier. Most orders placed before 3pm are dispatched the same working day. You'll receive your medication in plain, unmarked packaging with no external indication of contents, and your prescriber will provide detailed injection technique guidance and ongoing support throughout your treatment journey.

What Happens After Your Consultation

After a UK prescriber approves your consultation, you'll receive an email confirmation with your prescription details and expected dispatch date. Your first Wegovy pen arrives with comprehensive instructions, alcohol swabs, and a sharps disposal container. We recommend scheduling your weekly injection on the same day each week to maintain consistent medication levels. Your prescriber remains available for follow-up questions via our patient portal, and you'll complete brief progress reviews every 12 weeks to monitor your weight loss response and adjust your prescription as needed.

Wegovy Side Effects and Clinical Considerations

The most common side effects of Wegovy are gastrointestinal and typically occur during the initial dose escalation phase. In clinical trials, nausea affected approximately 44% of participants, whilst vomiting, diarrhoea, and constipation occurred in 24%, 30%, and 24% respectively [1]. These effects usually diminish significantly after the first 8-12 weeks as your body adjusts to the medication.

More serious but rare side effects include pancreatitis, gallbladder disease, and hypoglycaemia in patients taking certain diabetes medications concurrently [2]. Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your UK prescriber will screen for these contraindications during your consultation and monitor for any concerning symptoms throughout your treatment. If you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction, you should discontinue Wegovy and seek immediate medical attention.

Wegovy Results: What to Expect

Clinical trial data shows that most patients begin experiencing noticeable weight loss within the first 4-8 weeks of starting Wegovy, with weight reduction accelerating as the dose increases [1]. By week 68 in the STEP 1 trial, 83.5% of participants achieved at least 5% body weight reduction, and 66.1% achieved at least 10% reduction [1]. Individual results vary based on adherence to dietary modifications, physical activity levels, and metabolic factors.

NICE guidelines recommend discontinuing Wegovy if a patient has not achieved at least 5% weight loss after 6 months at the maintenance dose [3]. Your UK prescriber will monitor your progress through regular weight measurements and clinical reviews. Most successful patients combine Wegovy with a structured dietary programme reducing caloric intake by 500-1000 calories daily and incorporating at least 150 minutes of moderate-intensity physical activity weekly. Weight loss typically plateaus after 60-68 weeks, at which point Wegovy serves to maintain the achieved weight reduction rather than produce further decreases.

Long-Term Weight Maintenance

The STEP 4 trial demonstrated that patients who discontinued Wegovy after 20 weeks regained approximately two-thirds of their lost weight over the subsequent 48 weeks, whilst those continuing treatment maintained their weight loss [4]. This evidence suggests Wegovy functions as a long-term management tool rather than a short-term intervention. Your prescriber will discuss realistic expectations for treatment duration during your initial consultation, typically recommending a minimum 12-month course for patients who respond well to the medication. Ongoing lifestyle modifications remain essential even whilst taking Wegovy, as the medication enhances but does not replace the fundamental behaviours required for sustained weight management.

Why Choose Cured Pharmacy for Wegovy

Cured Pharmacy offers transparent upfront pricing with Wegovy available from £79.00, significantly lower than typical market rates. Unlike some providers who reveal costs only after consultation, we display all prices clearly before you begin your assessment. Our lowest price guarantee ensures you're receiving competitive UK pricing without compromising on clinical quality or pharmaceutical standards.

As a fully registered UK pharmacy (GPhC 9012511) with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing all clinical operations, we dispense only genuine UK-licensed Wegovy sourced directly from authorised wholesalers. Every prescription undergoes individual review by a UK-registered prescriber, and we maintain complete stock of all Wegovy doses to prevent treatment interruptions. Our patient support team is available via phone (+44 116 4646009) during working hours, and our secure patient portal allows you to message your prescriber directly with any clinical questions throughout your treatment journey.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Davies, M., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine licensed for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities, alongside a reduced-calorie diet and increased physical activity.